Publication Cover
Redox Report
Communications in Free Radical Research
Volume 28, 2023 - Issue 1
1,463
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation

ORCID Icon, , , , &

References

  • Breglio AM, Rusheen AE, Shide ED, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017 Nov 21;8(1):1654.
  • Brock PR, Maibach R, Childs M, et al. Sodium Thiosulfate for protection from Cisplatin-Induced hearing loss. N Engl J Med. 2018 Jun 21;378(25):2376–2385.
  • Kim SJ, Park C, Han AL, et al. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res. 2009 May;251(1–2):70–82.
  • Park HJ, Kim MJ, Rothenberger C, et al. GSTA4 mediates reduction of cisplatin ototoxicity in female mice. Nat Commun. 2019 Sep 12;10(1):4150.
  • Tang Q, Wang X, Jin H, et al. Cisplatin-induced ototoxicity: updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm. 2021 Jun;163:60–71.
  • Hoshino T, Tabuchi K, Nishimura B, et al. Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity. Biochem Biophys Res Commun. 2011 Nov 11;415(1):94–98.
  • Zhang W, Xiong H, Pang J, et al. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production. Toxicol Lett. 2020 Oct 1;331:1–10.
  • Mirzaei S, Mohammadi AT, Gholami MH, et al. Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance. Pharmacol Res. 2021 May;167:105575.
  • So HS, Kim HJ, Lee JH, et al. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell Death Differ. 2006 Oct;13(10):1763–1775.
  • Jo ER, Youn CK, Jun Y, et al. The protective role of ferulic acid against cisplatin-induced ototoxicity. Int J Pediatr Otorhinolaryngol. 2019 May;120:30–35.
  • Oishi T, Matsumaru D, Ota N, et al. Activation of the NRF2 pathway in Keap1-knockdown mice attenuates progression of age-related hearing loss. NPJ Aging Mech Dis. 2020 Dec 14;6(1):14.
  • Delhez A, Lefebvre P, Pequeux C, et al. Auditory function and dysfunction: estrogen makes a difference. Cell Mol Life Sci. 2020 Feb;77(4):619–635.
  • Ishii T, Warabi E. Mechanism of rapid nuclear factor-E2-related factor 2 (Nrf2) activation via membrane-associated estrogen receptors: roles of NADPH oxidase 1, Neutral Sphingomyelinase 2 and Epidermal Growth Factor Receptor (EGFR). Antioxidants (Basel). 2019 Mar 18;8(3).
  • Nakamagoe M, Tabuchi K, Uemaetomari I, et al. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Hear Res. 2010 Mar;261(1–2):67–74.
  • Hu XJ, Li FF, Wang Y, et al. Effects of cisplatin on the auditory function of ovariectomized rats with estrogen deficiency. Acta Otolaryngol. 2017 Jun;137(6):606–610.
  • Van de Water T, Ruben RJ. Growth of the inner ear in organ culture. Ann Otol Rhinol Laryngol. 1974 Sep-Oct;83(5 Pt 2 Suppl 14):1–16.
  • Sobkowicz HM, Loftus JM, Slapnick SM. Tissue culture of the organ of Corti. Acta Otolaryngol Suppl. 1993;502:3–36.
  • Le Q, Tabuchi K, Hara A. Ceramide-1-phosphate protection of cochlear hair cells against cisplatin ototoxicity. Toxicol Rep. 2016;3:450–457.
  • Hall MD, Telma KA, Chang KE, et al. Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes. Cancer Res. 2014 Jul 15;74(14):3913–3922.
  • Tabuchi K, Pak K, Chavez E, et al. Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience. 2007 Oct 12;149(1):213–222.
  • Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013 Mar;48(3):452–458.
  • Tani K, Tabuchi K, Hara A. Hair cell loss induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea. Neurotox Res. 2016 Jan;29(1):35–46.
  • Paciello F, Fetoni AR, Mezzogori D, et al. The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. Sci Rep. 2020 Jan 23;10(1):1063.
  • Marcu LG. Gender and sex-Related differences in Normal tissue effects induced by platinum compounds. Pharmaceuticals (Basel). 2022 Feb 20;15(2):255.
  • Hellgren M, Conard J, Norris L, et al. Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone. Maturitas. 2009 Mar 20;62(3):287–293.